LTTS2020-10-012020-12-31in-bse-fin:OneOperatingExpenses01Member LTTS2020-10-012020-12-31in-bse-fin:FourOperatingExpenses01Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentRevenue01Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentRevenue02Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentRevenue03Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentRevenue04Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentRevenue05Member LTTS2020-10-012020-12-31in-bse-fin:FourReportableSegmentRevenue01Member LTTS2020-10-012020-12-31in-bse-fin:FourReportableSegmentRevenue02Member LTTS2020-10-012020-12-31in-bse-fin:FourReportableSegmentRevenue03Member LTTS2020-10-012020-12-31in-bse-fin:FourReportableSegmentRevenue04Member LTTS2020-10-012020-12-31in-bse-fin:FourReportableSegmentRevenue05Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentResults01Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentResults02Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentResults03Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentResults04Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentResults05Member LTTS2020-10-012020-12-31in-bse-fin:FourReportableSegmentResults01Member LTTS2020-10-012020-12-31in-bse-fin:FourReportableSegmentResults02Member LTTS2020-10-012020-12-31in-bse-fin:FourReportableSegmentResults03Member LTTS2020-10-012020-12-31in-bse-fin:FourReportableSegmentResults04Member LTTS2020-10-012020-12-31in-bse-fin:FourReportableSegmentResults05Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentAssets01Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentAssets02Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentAssets03Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentAssets04Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentAssets05Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentLiabilities01Member LTTS2020-12-31in-bse-fin:OneReportableSegmentLiabilities01Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentLiabilities02Member LTTS2020-12-31in-bse-fin:OneReportableSegmentLiabilities02Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentLiabilities03Member LTTS2020-12-31in-bse-fin:OneReportableSegmentLiabilities03Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentLiabilities04Member LTTS2020-12-31in-bse-fin:OneReportableSegmentLiabilities04Member LTTS2020-10-012020-12-31in-bse-fin:OneReportableSegmentLiabilities05Member LTTS2020-12-31in-bse-fin:OneReportableSegmentLiabilities05Member LTTS2020-10-012020-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member LTTS2020-10-012020-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member LTTS2020-10-012020-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member LTTS2020-10-012020-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member LTTS2020-10-012020-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member LTTS2020-10-012020-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member LTTS2020-10-012020-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member LTTS2020-10-012020-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares LTTS 2020-04-01 2021-03-31 2020-12-31 INR Millions Third quarter Multi segment 2020-10-01 2020-12-31 Unaudited Standalone 12676000000.00 484000000.00 13160000000.00 0.00 0.00 0.00 7569000000.00 103000000.00 439000000.00 2512000000.00 10623000000.00 2537000000.00 0.00 2537000000.00 639000000.00 0.00 639000000.00 0.00 1898000000.00 0.00 0.00 0.00 0.00 1898000000.00 505000000.00 2403000000.00 2403000000.00 0.00 210000000.00 2 18.10 17.97 0.00 0.00 18.10 17.97 0.00 0.00 0.00 1.The standalone unaudited financial results for the quarter and nine months ended December 31, 2020 been taken on record by the Board of Directors at its meeting held on January 20, 2021. The statutory auditors have carried out limited review of the above standalone unaudited financial results and have issued an unqualified limited review report. The results for quarter and nine months ended December 31, 2020 are extracted from the unaudited interim standalone financial statements. These standalone interim financial statements are prepared in accordance with the Indian Accounting Standards (Ind-AS) as prescribed under section 133 of the Companies Act, 2013 read with rule 3 of the Companies (Indian Accounting Standards) Rules, 2015 and amendments thereto. n2.During the quarter ended December 31, 2020, the Company has allotted 127,735 equity shares of Rs. 2 each fully paid-up on exercise of stock options by employees, in accordance with the Company's stock option scheme. n3.Estimation uncertainty relating to COVID-19: nThe Company has considered internal and certain external sources of information including reliable credit reports, economic forecasts and industry reports up to the date of approval of the financial results in determining the impact on various elements of its financial results. The Company has used the principles of prudence in applying judgments, estimates and assumptions including sensitivity analysis and based on current estimates, the Company expects to fully recover the carrying amount of trade receivables including unbilled receivables, intangible assets and investments. Management of the Company has also reviewed goodwill and is of the opinion that no impairment is required at present. The eventual outcome of impact of the global health pandemic may be different from those estimated as on the date of approval of these financial results. n4.The Code on Social Security, 2020 has been enacted, which would impact contributions by the Company towards Provident Fund and Gratuity. The effective date from which the changes are applicable is yet to be notified and the rules for quantifying the financial impact are yet to be framed. The Ministry of Labour and Employment has released draft rules for the Code on Social Security, 2020 on November 13, 2020, and has invited suggestions from stakeholders which are under active consideration by the Ministry. The Company will complete its evaluation and will give appropriate impact in its financial results in the period in which, the Code becomes effective and the related rules are published. n5.Figures for earlier periods have been regrouped, wherever necessary. Multi segment 2020-04-01 2020-12-31 Unaudited Standalone 36610000000.00 1378000000.00 37988000000.00 0.00 0.00 0.00 22451000000.00 320000000.00 1303000000.00 7475000000.00 31549000000.00 6439000000.00 0.00 6439000000.00 1480000000.00 134000000.00 1614000000.00 0.00 4825000000.00 0.00 0.00 0.00 0.00 4825000000.00 2315000000.00 7140000000.00 7140000000.00 0.00 210000000.00 2 46.10 45.79 0.00 0.00 46.10 45.79 0.00 0.00 0.00 OTHER EXPENSES 2512000000.00 OTHER EXPENSES 7475000000.00 Industrial Products 2565000000.00 Medical Devices 1765000000.00 Plant Engineering 2037000000.00 Telecom & Hitech 2577000000.00 Transportation 3732000000.00 Industrial Products 7400000000.00 Medical Devices 5106000000.00 Plant Engineering 5712000000.00 Telecom & Hitech 7522000000.00 Transportation 10870000000.00 12676000000.00 36610000000.00 0.00 0.00 12676000000.00 36610000000.00 Industrial Products 760000000.00 Medical Devices 547000000.00 Plant Engineering 488000000.00 Telecom & Hitech 324000000.00 Transportation 604000000.00 Industrial Products 2025000000.00 Medical Devices 1578000000.00 Plant Engineering 1144000000.00 Telecom & Hitech 913000000.00 Transportation 1472000000.00 2723000000.00 7132000000.00 103000000.00 320000000.00 83000000.00 a.Segments have been identified in accordance with Indian Accounting Standards ( Ind AS ) 108 on Operating Segments, considering the risk/return profiles of the business, their organisational structure and internal reporting systems. n nb.Property, plant and equipment used and liabilities contracted for performing the Company's business have not been identified to any of the above reported nsegments as the property, plant and equipment and services are used interchangeably among segments. 373000000.00 2537000000.00 6439000000.00 Industrial Products 0.00 Medical Devices 0.00 Plant Engineering 0.00 Telecom & Hitech 0.00 Transportation 0.00 0.00 0.00 0.00 Industrial Products 0.00 Medical Devices 0.00 Plant Engineering 0.00 Telecom & Hitech 0.00 Transportation 0.00 0.00 0.00 0.00